Related Experiment Video
Updated: Aug 25, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[Pharmacokinetics of lipophen--a novel combined phospholipid liver protective agent of natural origin]
1Central Research Institute, National Pharmaceutical Academy of Ukraine, ul. Pushkinskaya 53, Kharkov, 310002 Ukraine.
Abstract:
Study of the labeled lipophen distribution in organs and tissues of experimental animals showed evidence of a nonlinear drug pharmacokinetics. The maximum amount of labeled lipophen accumulated in liver, spleen, and kidneys, while the drug content in heart, muscles, and brain was very small. The products of lipophen metabolism are excreted with both urine and feces.
Related Concept Videos
Pharmacokinetics: Overview
Drug Biotransformation: Overview
First Pass Effect
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Bioavailability Enhancement: Drug Permeability Enhancement

